Skip to content

Skin irritation and sensitization trial

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525269-34-00
Enrollment
230
Registered
2026-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The intended indication is for the treatment of major depressive disorder.

Interventions

None listed

Sponsors

CCDRD Cooperative Clinical Drug Research and Development AG, Corium Innovations Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 27, 2026